Thank you, ISPOR Boston Chapter.
Ajibade Ashaye, MD MBA
BioPharma Leader | Venture Capital | Value, Evidence & Outcomes Strategy | Advisor | Board Member
As we round off what has been, a challenging year, I want to acknowledge you, the members of the #ISPORBostonRegionalChapter for all we were able to achieve together as a community. On behalf of the board, we thank you for your engagement, ideas, suggestions, and for allowing us to serve you.
Special thanks to our speakers/panelists who shared generously of their expertise in 2020.
- Rena Conti, PhD., Associate Professor, Markets, Public Policy, and Law; Associate Research Director, Institute for Health System Innovation and Policy, Boston University Questrom School of Business. “New Pricing Policies for New Cures: What Can We Learn from Louisiana?” March 2020
- Dana DiBenedetti, PhD., Executive Director, & Ari Gnanasakthy, MBA, MSc, Principal Scientist, Patient-Centered Outcomes Assessment, #RTI-HS. Patient Experience Data: Introduction to Strategic, Labeling, and Methodologic Considerations. June 2020
- Susan Garfield, DrPH, EY; Kathleen Gondek, PhD., Takeda Pharmaceuticals; Paige Lin, PhD., Tufts Medical Center; Amy O'Sullivan, PhD., Alkermes; Josephine Li-McLeod, RPh, PhD., Stratevi. Panel Discussion - Experiences and Insights from Women Leaders in #HEOR October 2020
I also want to acknowledge the current members of the #ISPORBostonBoard for their dedication and nimbleness - Josephine Li-McLeod, RPh, PhD., Stratevi; Paige Lin, PhD., Tufts Medical Center; Amy O'Sullivan, PhD., Alkermes; Noam Kirson, PhD., Analysis Group; Lisa Meckley, PhD., Takeda, Matt Sussman, PhD., Panalgo (formerly BHE); Nicole Benjamin Johnson, BS, Biogen; Ellison Suthoff, MBA, Sage Therapeutics. Thank you!
Following our elections in late November, we welcomed Nick Li, PhD., UniQURE to the board, as a Director, and Noam Kirson, PhD., Analysis Group, previously a Director, as #President-Elect for FY21. Amy O'Sullivan, PhD., Alkermes, and I, will be serving in new capacities in FY21 - as #President and #Past-President, respectively. Nicole Johnson and Lisa Meckley complete their term in December 2020. I'd like to thank Nicole and Lisa for their tireless efforts and contributions to the board – Lisa is a founding member of the Board.
I hope you get to enjoy this time with family, friends, and loved ones in a safe manner. Happy holidays and best wishes for 2021 – we look forward to your continued support and engagement.
Many thanks,
Ajibade O. Ashaye, MD, MBA | Takeda Pharmaceuticals Inc.
Chief Public Health Officer, Americas; Global Client Service Partner at EY
3 年Thanks for your leadership Ajibade. #ispor
Thank you for your great leadership, Ajibade!